Andreessen Horowitz holds final closing of third biotech fund

The California firm raised $750 million for its latest venture capital vehicle.

4 February 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.